Jean Jacques Bienaime - Net Worth and Insider Trading

Jean Jacques Bienaime Net Worth

The estimated net worth of Jean Jacques Bienaime is at least $61 Million dollars as of 2022-12-02. Jean Jacques Bienaime is the CEO of Biomarin Pharmaceutical Inc and owns about 570,357 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $61 Million. Jean Jacques Bienaime is the Director of Incyte Corp and owns about 8,646 shares of Incyte Corp (INCY) stock worth over $710,744. Jean Jacques Bienaime is also the Director of Immunic Inc and owns about 463 shares of Immunic Inc (IMUX) stock worth over $627. Details can be seen in Jean Jacques Bienaime's Latest Holdings Summary section.

Transaction Summary of Jean Jacques Bienaime

To
Not Enough Data to Display

Jean Jacques Bienaime Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jean Jacques Bienaime owns 5 companies in total, including Incyte Corp (INCY) , Biomarin Pharmaceutical Inc (BMRN) , and Immunic Inc (IMUX) among others .

Click here to see the complete history of Jean Jacques Bienaime’s form 4 insider trades.

Insider Ownership Summary of Jean Jacques Bienaime

Ticker Comapny Transaction Date Type of Owner
INCY Incyte Corp 2015-01-20 director
BMRN Biomarin Pharmaceutical Inc 2005-05-11 director & Chief Executive Officer
IMUX Immunic Inc 2015-09-09 director
PTLA Portola Pharmaceuticals Inc 2014-05-16 director
NGSX NeurogesX Inc 2012-02-07 director

Jean Jacques Bienaime Latest Holdings Summary

Jean Jacques Bienaime currently owns a total of 3 stocks. Among these stocks, Jean Jacques Bienaime owns 570,357 shares of Biomarin Pharmaceutical Inc (BMRN) as of October 31, 2022, with a value of $61 Million and a weighting of 98.84%. Jean Jacques Bienaime owns 8,646 shares of Incyte Corp (INCY) as of November 10, 2020, with a value of $710,744 and a weighting of 1.16%. Jean Jacques Bienaime also owns 463 shares of Immunic Inc (IMUX) as of September 24, 2018, with a value of $627 and a weighting of 0%.

Latest Holdings of Jean Jacques Bienaime

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMRN Biomarin Pharmaceutical Inc 2022-10-31 570,357 106.48 60,731,556
INCY Incyte Corp 2020-11-10 8,646 82.21 710,744
IMUX Immunic Inc 2018-09-24 463 1.36 627

Holding Weightings of Jean Jacques Bienaime


Jean Jacques Bienaime Form 4 Trading Tracker

According to the SEC Form 4 filings, Jean Jacques Bienaime has made a total of 72 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 72 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 1,500 shares on October 31, 2022, which brought Jean Jacques Bienaime around $129,825.

According to the SEC Form 4 filings, Jean Jacques Bienaime has made a total of 3 transactions in Incyte Corp (INCY) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Incyte Corp is the sale of 798 shares on November 10, 2020, which brought Jean Jacques Bienaime around $66,234.

According to the SEC Form 4 filings, Jean Jacques Bienaime has made a total of 2 transactions in Immunic Inc (IMUX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Immunic Inc is the sale of 665 shares on September 24, 2018, which brought Jean Jacques Bienaime around $7,986.

Insider Trading History of Jean Jacques Bienaime

Ticker Company Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Current Price Price Change Since Insider Trade (%) Filing Date
BMRN
Biomarin Pharmaceutical Inc
2022-10-31 Sell
1,500.00
-0.26%
$86.55
$129,825.00
570,357.00
$106.48
23.03%
2022-11-01
BMRN
Biomarin Pharmaceutical Inc
2022-10-14 Sell
4,000.00
-0.69%
$89.89
$359,560.00
571,857.00
$106.48
18.46%
2022-10-18
BMRN
Biomarin Pharmaceutical Inc
2022-08-15 Sell
7,000.00
-1.20%
$94.95
$664,650.00
575,857.00
$106.48
12.14%
2022-08-16
BMRN
Biomarin Pharmaceutical Inc
2022-05-06 Sell
30,000.00
-4.90%
$82.05
$2,461,500.00
582,857.00
$106.48
29.77%
2022-05-09
BMRN
Biomarin Pharmaceutical Inc
2022-04-29 Sell
25,000.00
-4.12%
$83.42
$2,085,500.00
582,516.00
$106.48
27.64%
2022-05-02
BMRN
Biomarin Pharmaceutical Inc
2022-04-18 Sell
20,000.00
-3.32%
$81.91
$1,638,200.00
582,516.00
$106.48
30.00%
2022-04-20
BMRN
Biomarin Pharmaceutical Inc
2022-04-14 Sell
10,000.00
-1.69%
$83.66
$836,600.00
582,516.00
$106.48
27.28%
2022-04-18
BMRN
Biomarin Pharmaceutical Inc
2022-01-13 Sell
10,000.00
-1.78%
$88.43
$884,300.00
551,322.00
$106.48
20.41%
2022-01-14
BMRN
Biomarin Pharmaceutical Inc
2021-12-16 Sell
12,000.00
-2.13%
$83.70
$1,004,400.00
551,222.00
$106.48
27.22%
2021-12-17
BMRN
Biomarin Pharmaceutical Inc
2021-12-01 Sell
1,500.00
-0.27%
$87.22
$130,830.00
551,922.00
$106.48
22.08%
-
BMRN
Biomarin Pharmaceutical Inc
2021-05-10 Sell
8,513.00
-1.52%
$77.29
$657,970.00
551,372.00
$106.48
37.77%
-
BMRN
Biomarin Pharmaceutical Inc
2021-05-07 Sell
50,000.00
-8.31%
$78.21
$3,910,500.00
551,372.00
$106.48
36.15%
-
BMRN
Biomarin Pharmaceutical Inc
2021-04-23 Sell
20,000.00
-3.51%
$79.13
$1,582,600.00
550,031.00
$106.48
34.56%
-
BMRN
Biomarin Pharmaceutical Inc
2021-03-12 Sell
14,000.00
-2.51%
$77.39
$1,083,460.00
543,185.00
$106.48
37.59%
-
BMRN
Biomarin Pharmaceutical Inc
2021-02-19 Sell
7,000.00
-1.27%
$83.58
$585,060.00
543,085.00
$106.48
27.40%
-
BMRN
Biomarin Pharmaceutical Inc
2021-02-18 Sell
7,000.00
-1.27%
$85.08
$595,560.00
543,085.00
$106.48
25.15%
-
BMRN
Biomarin Pharmaceutical Inc
2021-02-17 Sell
8,000.00
-1.45%
$84.54
$676,320.00
543,085.00
$106.48
25.95%
-
BMRN
Biomarin Pharmaceutical Inc
2021-01-29 Sell
16,667.00
-2.98%
$82.79
$1,379,860.00
543,085.00
$106.48
28.61%
-
BMRN
Biomarin Pharmaceutical Inc
2021-01-27 Sell
8,333.00
-1.51%
$85.49
$712,388.00
543,085.00
$106.48
24.55%
-
BMRN
Biomarin Pharmaceutical Inc
2020-12-29 Sell
3,000.00
-0.55%
$88.48
$265,440.00
543,085.00
$106.48
20.34%
-
Total 266
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jean Jacques Bienaime Trading Performance

GuruFocus tracks the stock performance after each of Jean Jacques Bienaime's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jean Jacques Bienaime is 24.97%. GuruFocus also compares Jean Jacques Bienaime's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jean Jacques Bienaime within 3 months outperforms 26 times out of 31 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jean Jacques Bienaime's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jean Jacques Bienaime

Average Relative Return

36.1%

Average relative return per transaction

Outperforming Transactions

77%

24 out of 31 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 9.6 24.97 31.33 36.1 37.84 10.41
Relative Return to S&P 500(%) 8.35 21.7 23.47 20.5 28.43 11.43

Jean Jacques Bienaime Ownership Network

Ownership Network List of Jean Jacques Bienaime

No Data

Ownership Network Relation of Jean Jacques Bienaime


Jean Jacques Bienaime Owned Company Details


Jean Jacques Bienaime Mailing Address

Above is the net worth, insider trading, and ownership report for Jean Jacques Bienaime. You might contact Jean Jacques Bienaime via mailing address: 925 Page Mill Road, Palo Alto Ca 94304.